{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T19:40:57Z","timestamp":1795030857908,"version":"4.10.2"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Most pancreatic cancer patients exhibit inherent resistance to radiation therapy, and the molecular mechanisms remain poorly understood. Here, we demonstrate that phosphoglycerate kinase 1 (PGK1), a key ATP-producing glycolytic enzyme, plays a critical role in pancreatic ductal adenocarcinoma (PDAC) radioresistance. In response to ionizing radiation (IR), casein kinase 2 (CK2) is activated and phosphorylates PGK1 at S256. Phosphorylated PGK1 interacts with microrchidia CW-type zinc finger 2 (MORC2). Importantly, PGK1 functions as a protein kinase and phosphorylates MORC2 at S711, thereby enhancing the DNA-dependent ATPase activity of MORC2 to facilitate chromatin remodeling and DNA repair. Disruption of CK2-mediated PGK1 phosphorylation or PGK1-dependent MORC2 phosphorylation sensitizes PDAC cells and mouse tumors to IR. Clinically, the levels of PGK1 pS256 and MORC2 pS711, which are mutually correlated, are positively associated with poor survival in radiotherapy-treated PDAC specimens. These findings highlight the critical role of the nonmetabolic functions of PGK1 in DNA damage repair and PDAC radioresistance.<\/jats:p>","DOI":"10.1038\/s41419-025-08177-9","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T15:17:49Z","timestamp":1762787869000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The glycolytic enzyme PGK1 phosphorylates MORC2 to Confer radioresistance in pancreatic ductal adenocarcinoma"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8542-5216","authenticated-orcid":false,"given":"Yingying","family":"Tong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoxian","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zezhou","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2483-4029","authenticated-orcid":false,"given":"Dong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"key":"8177_CR1","doi-asserted-by":"publisher","DOI":"10.1148\/rg.230054","volume":"43","author":"FH Miller","year":"2023","unstructured":"Miller FH, Lopes Vendrami C, Hammond NA, Mittal PK, Nikolaidis P, Jawahar A. Pancreatic cancer and its mimics. Radiographics. 2023;43:e230054.","journal-title":"Radiographics"},{"key":"8177_CR2","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41586-019-1130-6","volume":"569","author":"Y Shi","year":"2019","unstructured":"Shi Y, Gao W, Lytle NK, Huang P, Yuan X, Dann AM, et al. Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring. Nature. 2019;569:131\u20135.","journal-title":"Nature"},{"key":"8177_CR3","doi-asserted-by":"crossref","unstructured":"Tong Y, Guo D, Yan D, Ma C, Shao F, Wang Y, et al. KAT2A succinyltransferase activity-mediated 14-3-3\u03b6 upregulation promotes \u03b2-catenin stabilization-dependent glycolysis and proliferation of pancreatic carcinoma cells. Cancer Lett. 2020;469:1\u201310.","DOI":"10.1016\/j.canlet.2019.09.015"},{"key":"8177_CR4","doi-asserted-by":"crossref","unstructured":"Tong Y, Guo D, Lin S-H, Liang J, Yang D, Ma C, et al. SUCLA2-coupled regulation of GLS succinylation and activity counteracts oxidative stress in tumor cells. Mol Cell. 2021;81:2303-16.","DOI":"10.1016\/j.molcel.2021.04.002"},{"key":"8177_CR5","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.1158\/0008-5472.CAN-23-1895","volume":"84","author":"M Zarei","year":"2024","unstructured":"Zarei M, Hajihassani O, Hue JJ, Loftus AW, Graor HJ, Nakazzi F, et al. IDH1 inhibition potentiates chemotherapy efficacy in pancreatic cancer. Cancer Res. 2024;84:3072\u201385.","journal-title":"Cancer Res"},{"key":"8177_CR6","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/S0140-6736(17)30126-5","volume":"389","author":"G Deplanque","year":"2017","unstructured":"Deplanque G, Demartines N. Pancreatic cancer: are more chemotherapy and surgery needed?. Lancet. 2017;389:985\u20136.","journal-title":"Lancet"},{"key":"8177_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41575-023-00840-w","volume":"21","author":"ZI Hu","year":"2024","unstructured":"Hu ZI, O\u2019Reilly EM. Therapeutic developments in pancreatic cancer. Nat Rev Gastroenterol Hepatol. 2024;21:7\u201324.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"8177_CR8","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41575-023-00856-2","volume":"21","author":"TF Stoop","year":"2024","unstructured":"Stoop TF, Theijse RT, Seelen LWF, Groot Koerkamp B, van Eijck CHJ, Wolfgang CL, et al. Preoperative chemotherapy, radiotherapy and surgical decision-making in patients with borderline resectable and locally advanced pancreatic cancer. Nat Rev Gastroenterol Hepatol. 2024;21:101\u201324.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"8177_CR9","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1038\/s41419-019-2072-5","volume":"10","author":"Y Jiang","year":"2019","unstructured":"Jiang Y, He R, Jiang Y, Liu D, Tao L, Yang M, et al. Transcription factor NFAT5 contributes to the glycolytic phenotype rewiring and pancreatic cancer progression via transcription of PGK1. Cell Death Dis. 2019;10:948.","journal-title":"Cell Death Dis"},{"key":"8177_CR10","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1016\/j.ymthe.2021.04.036","volume":"29","author":"Z Chu","year":"2021","unstructured":"Chu Z, Huo N, Zhu X, Liu H, Cong R, Ma L, et al. FOXO3A-induced LINC00926 suppresses breast tumor growth and metastasis through inhibition of PGK1-mediated Warburg effect. Mol Ther. 2021;29:2737\u201353.","journal-title":"Mol Ther"},{"key":"8177_CR11","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/j.1755-5949.2012.00353.x","volume":"18","author":"H Yan","year":"2012","unstructured":"Yan H, Yang K, Xiao H, Zou YJ, Zhang WB, Liu HY. Over-expression of cofilin-1 and phosphoglycerate kinase 1 in astrocytomas involved in pathogenesis of radioresistance. CNS Neurosci Ther. 2012;18:729\u201336.","journal-title":"CNS Neurosci Ther"},{"key":"8177_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-2050-y","volume":"10","author":"J Zhang","year":"2019","unstructured":"Zhang J, Zhang J, Wei Y, Li Q, Wang Q. ACTL6A regulates follicle-stimulating hormone-driven glycolysis in ovarian cancer cells via PGK1. Cell Death Dis. 2019;10:811.","journal-title":"Cell Death Dis"},{"key":"8177_CR13","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1080\/15384101.2016.1179037","volume":"15","author":"X Li","year":"2016","unstructured":"Li X, Zheng Y, Lu Z. PGK1 is a new member of the protein kinome. Cell Cycle. 2016;15:1803\u20134.","journal-title":"Cell Cycle"},{"key":"8177_CR14","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.molcel.2016.02.009","volume":"61","author":"X Li","year":"2016","unstructured":"Li X, Jiang Y, Meisenhelder J, Yang W, Hawke DH, Zheng Y, et al. Mitochondria-translocated PGK1 functions as a protein kinase to coordinate glycolysis and the TCA cycle in tumorigenesis. Mol Cell. 2016;61:705\u201319.","journal-title":"Mol Cell"},{"key":"8177_CR15","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.molcel.2017.01.027","volume":"65","author":"X Qian","year":"2017","unstructured":"Qian X, Li X, Cai Q, Zhang C, Yu Q, Jiang Y, et al. Phosphoglycerate Kinase 1 Phosphorylates Beclin1 to Induce Autophagy. Mol Cell. 2017;65:917\u201331.e6.","journal-title":"Mol Cell"},{"key":"8177_CR16","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.molcel.2018.09.007","volume":"72","author":"X Li","year":"2018","unstructured":"Li X, Qian X, Jiang H, Xia Y, Zheng Y, Li J, et al. Nuclear PGK1 alleviates ADP-Dependent inhibition of CDC7 to promote DNA replication. Mol Cell. 2018;72:650\u201360.e8.","journal-title":"Mol Cell"},{"key":"8177_CR17","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.cell.2013.07.011","volume":"154","author":"GJ Narlikar","year":"2013","unstructured":"Narlikar GJ, Sundaramoorthy R, Owen-Hughes T. Mechanisms and functions of ATP-dependent chromatin-remodeling enzymes. Cell. 2013;154:490\u2013503.","journal-title":"Cell"},{"key":"8177_CR18","doi-asserted-by":"publisher","first-page":"685","DOI":"10.4161\/epi.24976","volume":"8","author":"D-Q Li","year":"2013","unstructured":"Li D-Q, Nair SS, Kumar R. The MORC family: new epigenetic regulators of transcription and DNA damage response. Epigenetics. 2013;8:685\u201393.","journal-title":"Epigenetics"},{"key":"8177_CR19","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1093\/gbe\/evy136","volume":"10","author":"W Dong","year":"2018","unstructured":"Dong W, Vannozzi A, Chen F, Hu Y, Chen Z, Zhang L. MORC domain definition and evolutionary analysis of the MORC gene family in green plants. Genome Biol Evol. 2018;10:1730\u201344.","journal-title":"Genome Biol Evol"},{"key":"8177_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03045-x","volume":"9","author":"CH Douse","year":"2018","unstructured":"Douse CH, Bloor S, Liu Y, Shamin M, Tchasovnikarova IA, Timms RT, et al. Neuropathic MORC2 mutations perturb GHKL ATPase dimerization dynamics and epigenetic silencing by multiple structural mechanisms. Nat Commun. 2018;9:651.","journal-title":"Nat Commun"},{"key":"8177_CR21","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1038\/ng.3878","volume":"49","author":"IA Tchasovnikarova","year":"2017","unstructured":"Tchasovnikarova IA, Timms RT, Douse CH, Roberts RC, Dougan G, Kingston RE, et al. Hyperactivation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2. Nat Genet. 2017;49:1035\u201344.","journal-title":"Nat Genet"},{"key":"8177_CR22","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/j.celrep.2012.11.018","volume":"2","author":"D-Q Li","year":"2012","unstructured":"Li D-Q, Nair SS, Ohshiro K, Kumar A, Nair VS, Pakala SB, et al. MORC2 signaling integrates phosphorylation-dependent, ATPase-coupled chromatin remodeling during the DNA damage response. Cell Rep. 2012;2:1657\u201369.","journal-title":"Cell Rep"},{"key":"8177_CR23","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/nrm.2017.67","volume":"18","author":"JC Saldivar","year":"2017","unstructured":"Saldivar JC, Cortez D, Cimprich KA. The essential kinase ATR: ensuring faithful duplication of a challenging genome. Nat Rev Mol Cell Biol. 2017;18:622\u201336.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8177_CR24","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/embor.2010.152","volume":"11","author":"M Shimada","year":"2010","unstructured":"Shimada M, Haruta M, Niida H, Sawamoto K, Nakanishi M. Protein phosphatase 1\u03b3 is responsible for dephosphorylation of histone H3 at Thr 11 after DNA damage. EMBO Rep. 2010;11:883\u20139.","journal-title":"EMBO Rep"},{"key":"8177_CR25","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/ncb1668","volume":"10","author":"E Metzger","year":"2008","unstructured":"Metzger E, Yin N, Wissmann M, Kunowska N, Fischer K, Friedrichs N, et al. Phosphorylation of histone H3 at threonine 11 establishes a novel chromatin mark for transcriptional regulation. Nat Cell Biol. 2008;10:53\u201360.","journal-title":"Nat Cell Biol"},{"key":"8177_CR26","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/nrc2248","volume":"7","author":"M L\u00f6brich","year":"2007","unstructured":"L\u00f6brich M, Jeggo PA. The impact of a negligent G2\/M checkpoint on genomic instability and cancer induction. Nat Rev Cancer. 2007;7:861\u20139.","journal-title":"Nat Rev Cancer"},{"key":"8177_CR27","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.molcel.2018.03.018","volume":"70","author":"JH Lee","year":"2018","unstructured":"Lee JH, Liu R, Li J, Wang Y, Tan L, Li XJ, et al. EGFR-phosphorylated platelet isoform of phosphofructokinase 1 promotes PI3K activation. Mol Cell. 2018;70:197\u2013210.e7.","journal-title":"Mol Cell"},{"key":"8177_CR28","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.ccell.2019.01.020","volume":"35","author":"J Ma","year":"2019","unstructured":"Ma J, Benitez JA, Li J, Miki S, Ponte de Albuquerque C, Galatro T, et al. Inhibition of nuclear PTEN tyrosine phosphorylation enhances glioma radiation sensitivity through attenuated DNA repair. Cancer Cell. 2019;35:504\u201318.e7.","journal-title":"Cancer Cell"},{"key":"8177_CR29","doi-asserted-by":"crossref","unstructured":"Guo D, Yu Q, Tong Y, Qian X, Meng Y, Ye F, et al. OXCT1 succinylation and activation by SUCLA2 promotes ketolysis and liver tumor growth. Mol Cell. 2025;85:843\u201356.","DOI":"10.1016\/j.molcel.2024.12.025"},{"key":"8177_CR30","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nmeth1048","volume":"4","author":"JJ Allen","year":"2007","unstructured":"Allen JJ, Li M, Brinkworth CS, Paulson JL, Wang D, Hubner A, et al. A semisynthetic epitope for kinase substrates. Nat Methods. 2007;4:511\u20136.","journal-title":"Nat Methods"},{"key":"8177_CR31","doi-asserted-by":"publisher","first-page":"6803","DOI":"10.1128\/MCB.17.12.6803","volume":"17","author":"D Tantin","year":"1997","unstructured":"Tantin D, Kansal A, Carey M. Recruitment of the putative transcription-repair coupling factor CSB\/ERCC6 to RNA polymerase II elongation complexes. Mol Cell Biol. 1997;17:6803\u201314.","journal-title":"Mol Cell Biol"},{"key":"8177_CR32","doi-asserted-by":"publisher","first-page":"3798","DOI":"10.1200\/JCO.2003.11.069","volume":"21","author":"FR Hirsch","year":"2003","unstructured":"Hirsch FR, Varella-Garcia M, Bunn PA Jr., Di Maria MV, Veve R, Bremmes RM, et al. Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. J Clin Oncol. 2003;21:3798\u2013807.","journal-title":"J Clin Oncol"},{"key":"8177_CR33","doi-asserted-by":"publisher","first-page":"15105","DOI":"10.1073\/pnas.0507722102","volume":"102","author":"SY Lin","year":"2005","unstructured":"Lin SY, Rai R, Li K, Xu ZX, Elledge SJ. BRIT1\/MCPH1 is a DNA damage responsive protein that regulates the Brca1-Chk1 pathway, implicating checkpoint dysfunction in microcephaly. Proc Natl Acad Sci USA. 2005;102:15105\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8177_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s10020-019-0079-0","volume":"25","author":"J-W Zhou","year":"2019","unstructured":"Zhou J-W, Tang J-J, Sun W, Wang H. PGK1 facilities cisplatin chemoresistance by triggering HSP90\/ERK pathway mediated DNA repair and methylation in endometrial endometrioid adenocarcinoma. Mol Med. 2019;25:11.","journal-title":"Mol Med"},{"key":"8177_CR35","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nprot.2006.5","volume":"1","author":"PL Olive","year":"2006","unstructured":"Olive PL, Ban\u00e1th JP. The comet assay: a method to measure DNA damage in individual cells. Nat Protoc. 2006;1:23\u20139.","journal-title":"Nat Protoc"},{"key":"8177_CR36","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1021\/pr300630k","volume":"12","author":"H Zhou","year":"2013","unstructured":"Zhou H, Di Palma S, Preisinger C, Peng M, Polat AN, Heck AJ, et al. Toward a comprehensive characterization of a human cancer cell phosphoproteome. J Proteome Res. 2013;12:260\u201371.","journal-title":"J Proteome Res"},{"key":"8177_CR37","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/ncb1446","volume":"8","author":"Y Ziv","year":"2006","unstructured":"Ziv Y, Bielopolski D, Galanty Y, Lukas C, Taya Y, Schultz DC, et al. Chromatin relaxation in response to DNA double-strand breaks is modulated by a novel ATM- and KAP-1 dependent pathway. Nat Cell Biol. 2006;8:870\u20136.","journal-title":"Nat Cell Biol"},{"key":"8177_CR38","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41392-020-0150-x","volume":"5","author":"RX Huang","year":"2020","unstructured":"Huang RX, Zhou PK. DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer. Signal Transduct Target Ther. 2020;5:60.","journal-title":"Signal Transduct Target Ther"},{"key":"8177_CR39","doi-asserted-by":"crossref","unstructured":"Kabakov AE, Yakimova AO. Hypoxia-induced cancer cell responses driving radioresistance of hypoxic tumors: approaches to targeting and radiosensitizing. Cancers. 2021;13:1102.","DOI":"10.3390\/cancers13051102"},{"key":"8177_CR40","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20180008","volume":"92","author":"P Montay-Gruel","year":"2019","unstructured":"Montay-Gruel P, Meziani L, Yakkala C, Vozenin MC. Expanding the therapeutic index of radiation therapy by normal tissue protection. Br J Radio. 2019;92:20180008.","journal-title":"Br J Radio"},{"key":"8177_CR41","doi-asserted-by":"publisher","first-page":"3182","DOI":"10.1002\/cncr.26651","volume":"118","author":"D Chatterjee","year":"2012","unstructured":"Chatterjee D, Katz MH, Rashid A, Varadhachary GR, Wolff RA, Wang H, et al. Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma: a predictor for patient outcome. Cancer. 2012;118:3182\u201390.","journal-title":"Cancer"},{"key":"8177_CR42","doi-asserted-by":"publisher","first-page":"E254","DOI":"10.1111\/ans.16665","volume":"91","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Liao S, You J. Pathological complete response after neoadjuvant therapy for pancreatic ductal adenocarcinoma does not equal cure. ANZ J Surg. 2021;91:E254\u2013e9.","journal-title":"ANZ J Surg"},{"key":"8177_CR43","doi-asserted-by":"publisher","first-page":"460","DOI":"10.3389\/fonc.2020.00460","volume":"10","author":"D Wittmann","year":"2020","unstructured":"Wittmann D, Hall WA, Christians KK, Barnes CA, Jariwalla NR, Aldakkak M, et al. Impact of neoadjuvant chemoradiation on pathologic response in patients with localized pancreatic cancer. Front Oncol. 2020;10:460.","journal-title":"Front Oncol"},{"key":"8177_CR44","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nature25003","volume":"552","author":"Y Wang","year":"2017","unstructured":"Wang Y, Guo YR, Liu K, Yin Z, Liu R, Xia Y, et al. KAT2A coupled with the \u03b1-KGDH complex acts as a histone H3 succinyltransferase. Nature. 2017;552:273\u20137.","journal-title":"Nature"},{"key":"8177_CR45","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1038\/s41589-024-01597-2","volume":"20","author":"M Li","year":"2024","unstructured":"Li M, Wang Z, Tao J, Jiang H, Yang H, Guo D, et al. Fructose-1,6-bisphosphatase 1 dephosphorylates and inhibits TERT for tumor suppression. Nat Chem Biol. 2024;20:1505\u201313.","journal-title":"Nat Chem Biol"},{"key":"8177_CR46","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ejca.2021.10.023","volume":"160","author":"JL van Dam","year":"2022","unstructured":"van Dam JL, Janssen QP, Besselink MG, Homs MYV, van Santvoort HC, van Tienhoven G, et al. Neoadjuvant therapy or upfront surgery for resectable and borderline resectable pancreatic cancer: a meta-analysis of randomised controlled trials. Eur J Cancer. 2022;160:140\u20139.","journal-title":"Eur J Cancer"},{"key":"8177_CR47","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1200\/JCO.21.02233","volume":"40","author":"E Versteijne","year":"2022","unstructured":"Versteijne E, van Dam JL, Suker M, Janssen QP, Groothuis K, Akkermans-Vogelaar JM, et al. Neoadjuvant chemoradiotherapy versus upfront surgery for resectable and borderline resectable pancreatic cancer: long-term results of the dutch randomized PREOPANC trial. J Clin Oncol. 2022;40:1220\u201330.","journal-title":"J Clin Oncol"},{"key":"8177_CR48","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1001\/jamaoncol.2021.0057","volume":"7","author":"M Reyngold","year":"2021","unstructured":"Reyngold M, O\u2019Reilly EM, Varghese AM, Fiasconaro M, Zinovoy M, Romesser PB, et al. Association of ablative radiation therapy with survival among patients with inoperable pancreatic cancer. JAMA Oncol. 2021;7:735\u20138.","journal-title":"JAMA Oncol"},{"key":"8177_CR49","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.radonc.2020.07.053","volume":"152","author":"DAS Toesca","year":"2020","unstructured":"Toesca DAS, Ahmed F, Kashyap M, Baclay JRM, von Eyben R, Pollom EL, et al. Intensified systemic therapy and stereotactic ablative radiotherapy dose for patients with unresectable pancreatic adenocarcinoma. Radiother Oncol. 2020;152:63\u20139.","journal-title":"Radiother Oncol"},{"key":"8177_CR50","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.molcel.2008.05.017","volume":"31","author":"AA Goodarzi","year":"2008","unstructured":"Goodarzi AA, Noon AT, Deckbar D, Ziv Y, Shiloh Y, L\u00f6brich M, et al. ATM signaling facilitates repair of DNA double-strand breaks associated with heterochromatin. Mol Cell. 2008;31:167\u201377.","journal-title":"Mol Cell"},{"key":"8177_CR51","doi-asserted-by":"crossref","unstructured":"Keane F, O\u2019Connor CA, Park W, Seufferlein T, O\u2019Reilly EM. Pancreatic Cancer: BRCA Targeted Therapy and Beyond. Cancers. 2023;15:2955.","DOI":"10.3390\/cancers15112955"},{"key":"8177_CR52","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.ijrobp.2015.05.037","volume":"93","author":"C Kan","year":"2015","unstructured":"Kan C, Zhang J. BRCA1 mutation: a predictive marker for radiation therapy?. Int J Radiat Oncol Biol Phys. 2015;93:281\u201393.","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08177-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08177-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08177-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T18:09:16Z","timestamp":1762884556000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08177-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8177"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-08177-9","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"assertion":[{"value":"28 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted in compliance with the principles of the Declaration of Helsinki. Informed consent was obtained from all the subjects. Ethics approval for human subjects was provided by the Ethics Committee of the Beijing Luhe Hospital. All mouse experiments were approved by the Institutional Animal Care and Use Committee of the Capital Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"824"}}